1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow isomyosmine: new trials by email Literature Review of isomyosmine trials Research Report on isomyosmine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty MYMD-1 600MG, MYMD-1 750mg, MYMD-1 900mg - Sarcopenia, Frailty | Phase 2 | Completed | TNF Pharmaceuticals, Inc. | 40 | 2022-02-01 | 2023-10-30 |
Frailty (1) · Sarcopenia (1)
United States (1)
Jeremy Walston, MD (1) · Leonard Dunn, MD (1) · Lon Lynn, DO (1)